Eli Lilly (LLY) ROA - Return on Assets
Current and historical Return on Equity (ROE) values for Eli Lilly (LLY) over the last 10 years.
|Medical||Large Cap Pharmaceutical||$95.476B||$21.222B|
|Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.|